Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Net Current Assets

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Net Current Assets (Including Current Investments) ₹211 Cr₹168 Cr₹69 Cr₹62 Cr₹28 Cr

What is the latest Net Current Assets ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Net Current Assets ratio of SYNCOM FORMULATIONS (INDIA) is ₹211 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹211 Cr
Mar2024₹168 Cr
Mar2023₹69 Cr
Mar2022₹62 Cr
Mar2017₹28 Cr

How is Net Current Assets of SYNCOM FORMULATIONS (INDIA) Trending?

Years Net Current Assets % Change
Mar2025 ₹211 Cr
25.20
Mar2024 ₹168 Cr
145.53
Mar2023 ₹69 Cr
11.35
Mar2022 ₹62 Cr
122.16
Mar2017 ₹28 Cr -

Compare Net Current Assets of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,335.7 Cr 2.4% 2.2% -35.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,667.0 Cr 1.4% -4.5% 6.5% Stock Analytics
DIVIS LABORATORIES ₹176,805.0 Cr 0.1% -2.5% -0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,554.0 Cr -2.7% 1.2% 39.3% Stock Analytics
CIPLA ₹109,120.0 Cr -2.3% -5.3% -9.8% Stock Analytics
DR REDDYS LABORATORIES ₹105,920.0 Cr -0.5% -4.7% -5.4% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

2.4%

2.2%

-35.4%

SENSEX

4.3%

2.6%

-6.4%


You may also like the below Video Courses